A REVIEW ON THE APPLICATION OF FLUORESCENCE IN SITU HYBRIDIZATION (FISH) IN PREDICTING POOR PROGNOSIS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)

EHA Library, Xiangli Chen, 4209203

CHARACTERISTICS OF RELAPSE IN PEDIATRIC PHILADELPHIA CHROMOSOME–POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA TREATED ACCORDING TO THE EORTC 58951 PROTOCOL

EHA Library, Lamia Issaoui, 4209204

ADULT T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: EPIDEMIOLOGICAL, CLINICO-BIOLOGICAL, AND THERAPEUTIC PROFILE

EHA Library, Amel Meliane, 4209205

ACUTE LEUKEMIA AND THROMBOSIS IN CHILDREN

EHA Library, Selin Aytac, 4209206

BEYOND MORPHOLOGY: A FLOW CYTOMETRIC RISK SCORE FOR IMMEDIATE IDENTIFICATION OF BCR3-GENOTYPE AND FATAL OUTCOMES IN ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Manel Kasdallah, 4209207

CLINICAL VALIDATION OF  NEXT-GENERATION SEQUENCING-BASED LIQUID BIOPSY ASSAY FOR PROGNOSIS ASSESSMENT OF MEASURABLE RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA

EHA Library, Noemí Álvarez Sánchez-Redondo, 4209208

RAMAN SPECTROSCOPY COMBINED WITH MACHINE LEARNING PREDICTS INITIAL TREATMENT RESPONSE IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, SuJun Gao, 4209209

A CROSS-CANCER INTEGRATIVE FRAMEWORK COMBINING MULTI-OMICS AND MICROWELL IMAGING REVEALS THERAPEUTIC MITOTIC VULNERABILITIES IN AML

EHA Library, Ryuta Niikura, 4209210

OVEREXPRESSION OF MCPIP1 SUPPRESSES THE MTOR PATHWAY VIA TSC2 UPREGULATION AND SYNERGIZES WITH VENETOCLAX IN ACUTE MYELOID LEUKEMIA

EHA Library, weiguang cui, 4209211

AML WITH ATYPICAL MYELODYSPLASIA-RELATED CYTOGENETICS: CHALLENGING THE ROLE OF RARE ABERRATIONS IN AML-MR CLASSIFICATION

EHA Library, Sandra Huber, 4209212

SERIALLY TRANSPLANTABLE PDX MODELS FOR AML SUBGROUPS FOR WHICH NO CELL LINE EXIST

EHA Library, Irmela Jeremias, 4209214

ALDH1A1 INHIBITION IN COMBINATION WITH HYPOMETHYLATING AGENTS AS A SALVAGE STRATEGY FOR RELAPSED/REFRACTORY AML

EHA Library, Mehak Shaikh, 4209215

PARASYMPATHETIC CHOLINERGIC SIGNALING SUSTAINS STEMNESS IN ACUTE MYELOID LEUKEMIA VIA PI3K/MTOR SIGNALING

EHA Library, Carsten Riether, 4209216

IMPACT OF THE GERMLINE SH2B3 RS111340708 SPLICING VARIANT ON CLINICAL OUTCOMES AND SIGNALING DEREGULATION IN CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA

EHA Library, Alessandro Beghini, 4209217

GFI1B LOSS IMPAIRS DNA DAMAGE REPAIR KINETICS IN ACUTE MYELOID LEUKEMIA

EHA Library, Zhenqian Huang, 4209218

CLINICAL IMPACT OF HEMODILUTION ON MEASURABLE RESIDUAL DISEASE ASSESSED BY FLOW CYTOMETRY

EHA Library, Lukas Haaksma, 4209219

MALT1 INHIBITION SUPPRESSES AML CELL GROWTH BY MODULATING THE KMT2D/NCOR2/C-MYC AXIS VIA MCPIP1 INDUCTION AND SYNERGIZES WITH VENETOCLAX.

EHA Library, weiguang cui, 4209220

DUAL-LAYER MOLECULAR SIGNATURES OF CEBPA AND DNMT3A IN AML SURVIVAL STRATIFICATION

EHA Library, Jairo Jattin-Balcázar, 4209221

ADVANCING MINIMAL RESIDUAL DISEASE (MRD) ASSESSMENT IN ACUTE MYELOID LEUKEMIA (AML): FROM CELLS TO VESICLES THROUGH NEXT GENERATION SEQUENCING (NGS) AND DIGITAL PCR (DPCR)

EHA Library, Alessandro Leoni, 4209222

METABOLOMIC SIGNATURES IN UNTREATED AML SERUM ASSOCIATED WITH IN VITRO SENSITIVITY TO SYK INHIBITION

EHA Library, Marte Brattås, 4209223

REVEALING METABOLITES MODULATING IMMUNOSUPPRESSION IN AML-TME

EHA Library, Natividad Alquezar Artieda, 4209224

SCREENING MITOCHONDRIAL-TARGETING COMPOUNDS IN AML IDENTIFIES MITOTAM AS A BROAD VENETOCLAX-SENSITIZER

EHA Library, Juan Coelho-Silva, 4209225

ALKBH1 EXPRESSION MARKS RNA/TRANSLATION AND MITOCHONDRIAL GENE PROGRAMS IN AML AND SUPPORTS A THERAPEUTICALLY TRACTABLE VULNERABILITY

EHA Library, Juan Coelho-Silva, 4209226

RESVERATROL SYNERGISTICALLY POTENTIATES VENETOCLAX-INDUCED APOPTOSIS IN ACUTE MYELOID LEUKEMIA BY CO-TARGETING THE C-MYC/MCL-1 SIGNALING AXIS

EHA Library, weiguang cui, 4209227

FAULT TREE ANALYSIS IDENTIFIES HIGH-RISK PATTERNS OF INDUCTION FAILURE AND EARLY MORTALITY IN AML

EHA Library, Mobina Shrestha, 4209228

CELL TYPE AWARE MULTIPLE INSTANCE LEARNING REVEALS ASSOCIATIONS BETWEEN GENETIC ALTERATIONS AND BONE MARROW CYTOMORPHOLOGY IN AML

EHA Library, Mikko Purhonen, 4209230

GUT MICROBIOME TRAJECTORIES DURING HIGH- AND LOW-INTENSITY FRONTLINE AML THERAPY AND ASSOCIATED OUTCOMES

EHA Library, Kuo-Kai Chin, 4209231

CPX-351 INHIBITS FUNGAL GROWTH AND PREVENTS INFECTIONS VIA A HEALTHY INTER-KINGDOM NETWORK

EHA Library, Luigina Romani, 4209232

INTEGRATION OF MULTIPLE RNA-SEQ DATASETS ENHANCES DEEP PROFILING OF NPM1-MUTATED FLT3-ITD NEGATIVE AML

EHA Library, Matteo Caridi, 4209233

DIFFERENTIAL NLRP3 INFLAMMASOME ACTIVATION IN LEUKEMIC BLASTS AND NON-BLAST BONE MARROW CELLS IN ACUTE MYELOID LEUKEMIA

EHA Library, Dimitri Bulté, 4209234

MONOCYTE-BASED TRANSPORT OF HSV-1 ONCOLYTIC VIRUSES FOR ENHANCED ACUTE MYELOID LEUKEMIA TARGETING

EHA Library, Alessandra Rossetto, 4209235

SINGLE-CELL ANALYSIS REVEALS HETEROGENEOUS HEMATOPOIETIC HIERARCHIES IN NPM1-MUTATED AML

EHA Library, Anna Giné-Vilalta, 4209236

PREDOMINANCE OF THE PML-RARA BCR3 ISOFORM AND ITS PROGNOSTIC IMPACT IN A TUNISIAN APL COHORT: IMPLICATIONS FOR RISK-ADAPTED THERAPY

EHA Library, Manel Kasdallah, 4209237

DYNAMIC BLOOD COUNT TRAJECTORIES IMPROVE SURVIVAL PREDICTION OF INTENSIVELY-TREATED AML PATIENTS OVER STANDARD ELN CLASSIFICATION

EHA Library, Katariina Luukkainen, 4209239

FOURIER-TRANSFORM INFRARED (FT-IR) SPECTROSCOPY OF PLASMA AS A LIQUID BIOPSY APPROACH FOR DISEASE MONITORING IN ACUTE MYELOID LEUKEMIA (AML) POST ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Alessandro Leoni, 4209240

METABOLIC AND INFLAMMATORY SIGNATURES ASSOCIATED WITH NAMPT AND SCD EXPRESSION IN ACUTE MYELOID LEUKEMIA

EHA Library, Pedro Antonio Gonçalves dos Santos, 4209241

IDENTIFICATION OF IMMUNE MODULATORS OF CAR-T CELLS TARGETING CD33 IN ACUTE MYELOID LEUKEMIA

EHA Library, Hugo Legenne, 4209242

OVEREXPRESSION OF MCPIP1 INDUCES APOPTOSIS IN ACUTE MYELOID LEUKEMIA CELLS VIA ACTIVATION OF THE ENDOPLASMIC RETICULUM STRESS PATHWAY

EHA Library, weiguang cui, 4209243

ASSOCIATIONS OF RS55829688 AND RS145204276 PROMOTER VARIANTS WITH LNCRNA GAS5 EXPRESSION IN AML: PROGNOSTIC SIGNIFICANCE AND FUNCTIONAL ANALYSIS

EHA Library, Đorđe Pavlović, 4209244

INHIBITION OF LYSOSOMAL DETOXIFICATION AND RECYCLING PATHWAYS IN ACUTE MYELOBLASTIC LEUKAEMIA

EHA Library, Régis Costello, 4209245

NGS-BASED MIRNA EXPRESSION ANALYSIS IN PATIENTS CLASSIFIED AS MDS/AML VS AML ACCORDING TO ICC 2022

EHA Library, Claudia Núñez-Torron Stock, 4209246

LEVELS OF 91 CIRCULATING INFLAMMATORY PROTEINS AND RISK OF ACUTE MYELOID LEUKEMIA : A MENDELIAN RANDOMIZATION STUDY

EHA Library, Huihui An, 4209247

EFFECT OF IRRADIATION ON CLONAL HETEROGENEITY OF AML IN NSG MICE

EHA Library, Jörg Cammenga, 4209248

ACUTE MYELOID LEUKEMIA DRIVEN BY RARE HNRNPH1::ERG FUSION IN A YOUNG ADULT, WITH DISTINCT RNASEQ-DETECTED TRANSCRIPTS AT DIAGNOSIS AND RELAPSE.

EHA Library, Pablo Prieto-Martinez, 4209249

TRANSCRIPTIONAL CHARACTERIZATION OF CELLULAR COMPONENTS OF THE IMMUNE SYSTEM IN REMISSION OF ACUTE MYELOID LEUKEMIA: PERIPHERAL BLOOD SINGLE-CELL RNA-SEQ DATA

EHA Library, Irina Baratova, 4209251

IMMUNOPHENOTYPIC ABERRATIONS IN ACUTE MYELOID LEUKEMIA AND THEIR IMPACT ON CLINICAL OUTCOMES AND PATIENT SURVIVAL

EHA Library, Reyhan Aliyeva, 4209252

DONOR-DERIVED LEUKEMIA FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: TEMPORAL GENOMIC EVOLUTION AND THE PUTATIVE CONTRIBUTION OF DONOR CLONAL HEMATOPOIESIS (CASE REPORT)

EHA Library, Ildar Barkhatov, 4209253

DETECTION OF PROGNOSTIC AND ACTIONABLE BIOMARKERS IN AML ON A SINGLE NEXT GENERATION SEQUENCING (NGS) ASSAY

EHA Library, Ghayas Issa, 4209254

EXPLORING THE ANTI-AML MECHANISMS OF COMPOUND ZHEBEI GRANULE VIA INTEGRATED NETWORK PHARMACOLOGY, TRANSCRIPTOMIC SEQUENCING, AND EXPERIMENTAL VALIDATION

EHA Library, Li Hou, 4209255

SYNERGISTIC ANTI-LEUKEMIC ACTIVITY OF HOMOHARRINGTONINE AND SELINEXOR IN ACUTE MYELOID LEUKEMIA VIA DUAL INHIBITION OF THE C-MYC/MCL-1 PATHWAY

EHA Library, weiguang cui, 4209256

IDENTIFICATION OF NEW SURFACE TARGETS ON LEUKEMIC STEM CELLS IN ACUTE MYELOID LEUKEMIA BY RNA-SEQ PROFILING

EHA Library, Karin Bauer, 4209257

FEASIBILITY AND CLINICAL IMPACT OF FLT3-ITD ULTRA-HIGH-SENSITIVE (UHS) NGS MRD ASSESSMENT IN A MULTICENTRIC CLINICAL ROUTINE SETTING.

EHA Library, Eleni Linskens, 4209258

PROGNOSTIC VALUE OF MEASURING LEUKEMIA STEM CELL FREQUENCY IN ACUTE MYELOID LEUKEMIA: A SYSTEMATIC REVIEW AND INDIVIDUAL PATIENT DATA META-ANALYSIS

EHA Library, Tom Reuvekamp, 4209259

BRIDGING THE GAP IN ACUTE MYELOID LEUKEMIA (AML): LONG-READ SEQUENCING (LRS) NANOPORE FOR COMPREHENSIVE SOMATIC GENOMIC CHARACTERIZATION AND METHYLATION PROFILING IN 4 PATIENTS

EHA Library, Sergiu Moraru, 4209260

THE IMPACT OF RNA SPLICEOSOME MUTATIONS ON THE TREATMENT EFFICACY AND SURVIVAL OF PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Miao He, 4209262

PATHWAY-LEVEL SUPPRESSION OF PURINERGIC, CALCIUM, AND MATRIX SIGNALING IN ACUTE MYELOID LEUKEMIA IDENTIFIED BY PRE-RANKED GSEA META-ANALYSIS

EHA Library, Anzhelika Chegodar, 4209263

THE U2AF1–EZH2–LNCRNA REGULATORY AXIS CONTROLS THE EXPRESSION OF GENES ASSOCIATED WITH MALIGNANT PHENOTYPES IN K562 CELLS VIA THE ALTERNATIVE SPLICING PATHWAY

EHA Library, Xiangli Chen, 4209264

TARGETING MIR551B-3P ELIMINATES LEUKEMIC STEM- AND PROGENITOR CELLS IN CD34-POSITIVE ACUTE MYELOID LEUKEMIA

EHA Library, Linda Smit, 4209265

CIRCULATING HISTONE PROFILING IDENTIFIES A DISTINCT PLASMA SIGNATURE IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Nikol Daskalova, 4209266

NGS-BASED COMPREHENSIVE GENOMIC PROFILING IMPROVES RISK STRATIFICATION AND THERAPEUTIC STRATEGY OF ACUTE MYELOID LEUKEMIA ACROSS AGE GROUPS

EHA Library, Angelo Zanniti, 4209267

HIGH-RISK UBTF TANDEM DUPLICATIONS IN PEDIATRIC AML: DETECTION CHALLENGES AND INTEGRATED CHARACTERIZATION IN A SINGLE-CENTER COHORT

EHA Library, Alba Crespo-Carrasco, 4209268

COMPARATIVE CHARACTERISTICS OF THE FORMATION AND EVOLUTION OF CHROMOSOMAL CLONAL ABNORMALITIES AT DIAGNOSIS OF ACUTE MYELOID LEUKEMIA

EHA Library, Kateryna Korets, 4209269

PRESENCE OF COMUTATIONS AND OTHER PROGNOSTIC FACTORS IN ACUTE MYELOID LEUKEMIA WITH NPM1 MUTATION. EXPERIENCE AT HOSPITAL UNIVERSITARIO DONOSTIA.

EHA Library, Marina Aranguren Ostolaza, 4209270

TP53-POSITIVE ACUTE MYELOID LEUKEMIA: A SINGLE-CENTER RETROSPECTIVE CASE SERIES

EHA Library, Gokhan Burul, 4209272

BCR::ABL1-POSITIVE ACUTE MYELOID LEUKEMIA: FROM CLASSICAL TO RARE TRANSCRIPTS IN UKRAINE PATIENTS

EHA Library, Olha Kravets, 4209273

NON-CODING RNA-GUIDED REGULATORY LANDSCAPES IN ACUTE MYELOID LEUKAEMIA

EHA Library, Aonghus Naughton, 4209274

SPLENIC INFARCTION AS INITIAL PRESENTATION OF ACUTE PROMYELOCYTIC LEUKEMIA COMPLICATED BY EARLY DIFFERENTIATION SYNDROME UNDER ATRA

EHA Library, EKRAM LAGHMARI, 4209275

CYTOGENETIC CHARACTERISTICS OF THE DISTRIBUTION OF ABNORMAL KARYOTYPES IN DIFFERENT AGE GROUPS IN ACUTE MYELOID LEUKEMIA

EHA Library, Kateryna Korets, 4209277

PROGNOSTIC ROLE OF MINIMAL RESIDUAL DISEASE IN THE TREATMENT OF PATIENTS WITH ACUTE MYELOID LEUKEMIA WITH NPM1 MUTATION.

EHA Library, Anna Drobinina, 4209278

EFFICACY AND SAFETY OF GILTERITINIB-BASED COMBINATION THERAPY IN RELAPSED/REFRACTORY FLT3-MUTATED ACUTE MYELOID LEUKEMIA: A REAL-WORLD MULTICENTER STUDY

EHA Library, Zhiying He, 4209279

SPLICING FACTOR MUTATION CLEARANCE AND TREATMENT OUTCOMES IN CLONAL MYELOID DISORDERS: A REFERRAL CENTER EXPERIENCE

EHA Library, Kittika Poonsombudlert, 4209280

CLINICAL CONCORDANCE AND DECISION SUPPORT UTILITY OF FUNCTIONAL PRECISION MEDICINE TESTING IN RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Weng Tong Ho, 4209281

CHARACTERISTICS AND OUTCOMES OF ACUTE MYELOID LEUKEMIA PATIENTS ADMITTED TO INTENSIVE CARE UNIT AT DIAGNOSIS AND INDUCTION CHEMOTHERAPY: A RETROSPECTIVE SINGLE CENTRE ANALYSIS.

EHA Library, Semra Aydin, 4209282

SAFETY AND EFFICACY OF MITOXANTRONE LIPOSOME COMBINED CHEMOTHERAPY IN THE TREATMENT OF MIXED PHENOTYPE ACUTE LEUKEMIA

EHA Library, Huiwen Jiang, 4209283

RADIOTHERAPY AS A STRATEGY FOR LOCAL DISEASE CONTROL IN EXTRAMEDULLARY AML – A RETROSPECTIVE COHORT STUDY

EHA Library, Louisa Fredrikson, 4209284

EFFECT OF CONCOMITANT WT1 OR DNMT3A MUTATIONS ON THE PROGNOSIS OF PATIENTS WITH CEBPA-MUTATED ACUTE MYELOID LEUKEMIA

EHA Library, Zheng Ge, 4209285

MACHINE LEARNING-GUIDED RISK STRATIFICATION IN ELDERLY AML BASED ON GENOMIC, IMMUNOPHENOTYPIC AND THERAPEUTIC PROFILES

EHA Library, Ling Zhang, 4209286

TREATMENT LANDSCAPE OF PATIENTS WITH ACUTE MYELOID LEUKEMIA OVER 70 YEARS OF AGE IN A SINGLE-CENTER COHORT BETWEEN 2011 AND 2025: ARE WE DOING BETTER?

EHA Library, Tomas Rivero Equiza, 4209287

DIVERGENT PROGNOSTIC ROLES OF CLL-1/CD123 LEUKEMIA-ASSOCIATED COMBINATIONS, REGULATORY T CELLS (TREGS) PERCENTAGE AND PD-1-EXPRESSING TREGS IN ADULT AMLS: A SINGLE CENTRE EXPERIENCE

EHA Library, Neha Singh, 4209288

VENETOCLAX PLUS GILTERITINIB FOR FLT3-MUTATED RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA: A SINGLE-CENTER EXPERIENCE

EHA Library, Francesca Crupi, 4209290

LISAFTOCLAX AS A NOVEL BCL-2 INHIBITOR: EFFICACY AND SAFETY IN INDUCTION OR RE-INDUCTION COMBINED REGIMENS FOR HEMATOLOGIC MALIGNANCIES

EHA Library, Mengze Hao, 4209291

VENETOCLAX PLUS MITOXANTRONE HYDROCHLORIDE LIPOSOME AND AZACITIDINE (VMA) IN RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA: A RETROSPECTIVE REAL-WORLD ANALYSIS

EHA Library, Zhuo Wan, 4209292

ELTROMBOPAG PLUS VENETOCLAX AND AZACITIDINE IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: A RETROSPECTIVE STUDY

EHA Library, Kaibo Zhu, 4209293

REAL-WORLD EXPERIENCE OF CLADRIBINE PLUS LOW-DOSE CYTARABINE AND VENETOCLAX IN PATIENTS WITH NEWLY DIAGNOSED AND RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Sarah Marini, 4209294

SALVAGE THERAPIES IN RELAPSED ACUTE MYELOID LEUKEMIA POST VENETOCLAX-BASED THERAPY: A MULTICENTER, REAL-WORLD STUDY

EHA Library, Yuxin Li, 4209295

WT1 2 LOG-REDUCTION AFTER INDUCTION CHEMOTHERAPY IN ACUTE MYELOID LEUKEMIA PATIENTS: AN UNEXPECTED PREDICTOR OF OUTCOME

EHA Library, Mariachiara Cuccaro, 4209296

SURVIVAL HETEROGENEITY ACCORDING TO CYTOGENETICS AND CO-MUTATION PATTERNS IN AML TREATED WITH AZACITIDINE–VENETOCLAX

EHA Library, Cristiano Machado de Freitas, 4209297

FLT3 INHIBITORS PLUS INTENSIVE CHEMOTHERAPY IN NEWLY DIAGNOSED FLT3-MUTATED AML: A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Shankar Biswas, 4209298

ADDING FLT3 INHIBITORS TO HMA+VEN IMPROVES OUTCOMES IN UNFIT FLT3-ITD+ AML: A MULTI-CENTER REAL-WORLD LANDMARK ANALYSIS

EHA Library, Hui Zhou, 4209299

ASSOCIATION BETWEEN PML::RARA ISOFORM AND CD34 EXPRESSION IN ACUTE PROMYELOCYTIC LEUKEMIA AND ITS CORRELATION WITH MORPHOLOGICAL SUBTYPE

EHA Library, María Florencia Sanchez, 4209301

ANALYTICAL RELIABILITY OF LARGE LANGUAGE MODELS IN NETWORK META-ANALYSIS: A VALIDATION STUDY IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA INELIGIBLE FOR INTENSIVE CHEMOTHERAPY

EHA Library, Judith Pérez-Granado, 4209302

VARIANT TOPOGRAPHY OF NPM1 MUTATIONS IN ACUTE MYELOID LEUKEMIA

EHA Library, Markie Zimmer, 4209303

REAL-WORLD OUTCOMES OF VENETOCLAX–AZACITIDINE IN RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Amjad Althobaiti, 4209304

CPX-351 LEADS TO HIGH RESPONSE RATES AND DURABLE OUTCOMES IN NPM1 MUTATED AML: AN ITALIAN MULTICENTRIC REAL-LIFE STUDY

EHA Library, Francesco Grimaldi, 4209305

ACUTE MYELOID LEUKEMIA IN THE TARGETED-THERAPY ERA: UNITED STATES VS HIGH-SDI TRENDS, 1990–2021

EHA Library, Tapan Giri, 4209306

WT1 MUTATION PREDICTED A HIGHER RISK OF RELAPSE IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INV(16)(P13Q22)

EHA Library, Shunjie Yu, 4209307

PRAGMATIC GERIATRIC FITNESS STRATIFICATION IN OLDER ACUTE MYELOID LEUKEMIA PATIENTS RECEIVING NON-INTENSIVE THERAPY: A RETROSPECTIVE SINGLE-CENTER STUDY

EHA Library, Lucía Gómez-Pérez, 4209308

CLINICAL CHARACTERISTICS OF PEDIATRIC ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES: A RETROSPECTIVE COHORT STUDY

EHA Library, Xinling Tu, 4209309

THE EFFECT OF TREATMENT INTENSITY AND THERAPY-RELATED STATUS ON SURVIVAL IN KMT2A-REARRANGED AML

EHA Library, Jack Shapiro, 4209310

CPX-351 IS ASSOCIATED WITH LOWER SEVERITY OF CUTANEOUS ADVERSE EVENTS DESPITE HIGHER REPORTING PROPORTIONS COMPARED WITH CYTARABINE OR DAUNORUBICIN: A DISPROPORTIONALITY ANALYSIS OF EUDRAVIGILANCE

EHA Library, Calogero Vetro, 4209311